<xmp id="swicy"><small id="swicy"></small>
  • <small id="swicy"></small><td id="swicy"><li id="swicy"></li></td>
  • <li id="swicy"></li>
  • <td id="swicy"></td>
  • <small id="swicy"></small>
  • CN / EN

    About us

    About usOur team


    Technoderma Medicines, Inc.is a clinical stage biopharmaceutical company.

    The company's current core research and development programs include innovative drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis and lupus. TDM-105795, the world's leading small-molecule drug candidate for the treatment of androgenic alopecia, has now completed 2a clinical trials. TDM-180935, a novel JAK1/TYK2 inhibitor for eczema/atopic dermatitis, also completed a Phase 1 clinical trial in December 2023 with favorable safety results.

    Our advantage

    • 2010

      成立于2010年

    • 800

      代銷優質產品

    • 10

      10年積累經驗

    • 50

      合作伙伴達50家

    The honors and qualifications we have received

    欧美激情一区二区三区成人,久草热线,亚洲欧美在线观看一区二区,三级欧美视频
    <xmp id="swicy"><small id="swicy"></small>
  • <small id="swicy"></small><td id="swicy"><li id="swicy"></li></td>
  • <li id="swicy"></li>
  • <td id="swicy"></td>
  • <small id="swicy"></small>